Skip to main content
. 2019 Oct 18;9:14960. doi: 10.1038/s41598-019-51530-0

Figure 2.

Figure 2

Biodistribution of [68Ga]Ga-DO3A-S01-GCG in NHP. Representative Maximum Intensity Projections (MIP) of biodistribution at four different time-points following [68Ga]Ga-DO3A-S01-GCG administration. (A) Quantification of tissue biodistribution by SUV measurements show that radioactivity retention occurs in the liver as well as kidney, while remaining tissues exhibit clearance of the radioactivity signal. (B) Bars represent averages ± SD from PET/CT examinations in n = 6 NHPs.